Original Research
Published on 17 Oct 2022
How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1036190
- 1,367 views
Type at least 3 characters
1,560 articles
Articles
Case Report
Published on 17 Oct 2022
Case report: Two cases of primary paratesticular liposarcoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1040458
- 2,354 views
- 2 citations
Original Research
Published on 14 Oct 2022
Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.983805
- 1,399 views
- 2 citations
Editorial
Published on 14 Oct 2022
Editorial: Influences in the progression of renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1059615
- 974 views
- 2 citations
Original Research
Published on 14 Oct 2022
Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1025195
- 2,746 views
- 3 citations
Review
Published on 14 Oct 2022
Cellular milieu in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.943583
- 4,069 views
- 8 citations
Original Research
Published on 13 Oct 2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990367
- 3,481 views
- 11 citations
Review
Published on 13 Oct 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1000888
- 5,308 views
- 6 citations
Systematic Review
Published on 12 Oct 2022
Whole-gland high-intensity focused ultrasound ablation and transurethral resection of the prostate in the patients with prostate cancer: A systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.988490
- 2,935 views
- 3 citations
Original Research
Published on 12 Oct 2022
Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975779
- 4,349 views
- 6 citations
Original Research
Published on 12 Oct 2022
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.964838
- 1,692 views
Original Research
Published on 11 Oct 2022
Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1008763
- 1,916 views
- 3 citations
Original Research
Published on 10 Oct 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1019057
- 1,506 views
- 2 citations
Original Research
Published on 10 Oct 2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1018285
- 3,588 views
- 8 citations
Original Research
Published on 10 Oct 2022
Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.994703
- 3,296 views
- 11 citations
Original Research
Published on 07 Oct 2022
Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.982267
- 2,527 views
- 3 citations